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Abstract
Background: IbeA-induced NF-kB signaling through its primary receptor vimentin as well as its co-receptor PSF is required
for meningitic E. coli K1 penetration and leukocyte transmigration across the blood-brain barrier (BBB), which are the
hallmarks of bacterial meningitis. However, it is unknown how vimentin and PSF cooperatively contribute to IbeA-induced
cytoplasmic activation and nuclear translocation of NF-kB, which are required for bacteria-mediated pathogenicities.
Methodology/Principal Findings: IbeA-induced E. coli K1 invasion, polymorphonuclear leukocyte (PMN) transmigration and
IKK/NF-kB activation are blocked by Caffeic acid phenethyl ester (CAPE), an inhibitor of NF-kB. IKKa/b phosphorylation is
blocked by ERK inhibitors. Co-immunoprecipitation analysis shows that vimentin forms a complex with IkB, NF-kB and
tubulins in the resting cells. A dissociation of this complex and a simultaneous association of PSF with NF-kB could be
induced by IbeA in a time-dependent manner. The head domain of vimentin is required for the complex formation. Two
cytoskeletal components, vimentin filaments and microtubules, contribute to the regulation of NF-kB. SiRNA-mediated
knockdown studies demonstrate that IKKa/b phosphorylation is completely abolished in HBMECs lacking vimentin and PSF.
Phosphorylation of ERK and nuclear translocation of NF-kB are entirely dependent on PSF. These findings suggest that
vimentin and PSF cooperatively contribute to IbeA-induced cytoplasmic activation and nuclear translocation of NF-kB
activation. PSF is essential for translocation of NF-kB and ERK to the nucleus.
Conclusion/Significance: These findings reveal previously unappreciated facets of the IbeA-binding proteins. Cooperative
contributions of vimentin and PSF to IbeA-induced cytoplasmic activation and nuclear translocation of NF-kB may represent
a new paradigm in pathogen-induced signal transduction and lead to the development of novel strategies for the
prevention and treatment of bacterial meningitis.
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Introduction
Over the past few years, studies of the common neonatal
bacterial meningitis caused by Escherichia coli K1 revealed the
importance and significance of IbeA, a major virulence determi-
nant during the early stage of neonatal E. coli infection [1], and its
interactions with host factors in brain microvascular endothelial
cells (BMEC), including vimentin (primary receptor), polypyrimi-
dine tract-binding protein (PTB)-associated splicing factor (PSF)
(co-receptor), and related signaling molecules (e.g., caveolin-1,
ERK, and CaMKII) [2–6]. The ibeA gene locus (GimA) is unique
to E. coli pathogens but is not present in nonpathogenic E. coli K12
strains [7–8]. It has been widely used as a genetic marker in the
genotyping of E. coli strains isolated from various host and
environmental sources [1,9–14]. The ibeA locus is able to modulate
expression of several virulence factors (e.g., aatA, fim, ibeB, ompA and
biofilm-associated genes) and predominantly contributes to E. coli
K1-caused early-onset human neonatal sepsis and meningitis by
inducing both pathogen penetration and polymorphonuclear
leukocyte (PMN) transmigration across the blood-brain barrier
(BBB), which consists mainly of BMEC [1,15–17]. IbeA is
positively associated with multidrug resistance [14,18]. The
specific IbeA–BMEC surface protein interaction and subsequently
induced signal transduction were shown to be essential for E. coli
K1 invasion [19–20]. Two IbeA-binding proteins have been
identified: vimentin, which is constitutively present in the surface
of human BMECs (HBMECs), and PSF, which is inducibly
expressed in both mesenchymal (endothelium) and non-mesen-
chymal (epithelium) cells [2–3]. IbeA-induced signaling through its
binding proteins vimentin as well as PSF is required for meningitic
E. coli K1 penetration across the blood-brain barrier (BBB), which
is one of the hallmarks of bacterial meningitis [4–6]. Vimentin is a
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[2]. Epithelial–mesenchymal transition (EMT) processes are
usually associated with embryonic development and the malignant
conversion of epithelial tumour cells [21]. This protein also
contributes to the adhesive or invasive phenotype of microbial
pathogens, including P. multocida and African swine fever virus [2].
Our previous studies have shown that CaMKII-induced phos-
phorylation of the vimentin head domain and the vimentin-
binding domain of ERK are necessary for IbeA+ E. coli K1-
mediated invasion of BMEC. PSF is mainly present in the nucleus,
but it can be translocated to the cytoplasm and cell surface [2]. It
has multiple functions, including binding of nucleic acids (DNA
and RNA) and proteins, DNA pairing, promotion of pre-mRNA
splicing and transcriptional regulation. Besides these properties,
PSF may contribute to regulation of protein kinase C [22] and
ERK [23]. Our recent study demonstrated that PSF could
contribute to IbeA-mediated E. coli K1 invasion of HBMECs in a
manner dependent on lipid rafts [2,4]. Upon stimulation with E.
coli K1 or IbeA-coated beads, vimentin and PSF are recruited to
the raft microdomains, suggesting that that lipid rafts in HBMECs
serve as a common platform for both proteins contributing to
IbeA-induced virulence. However, it is unknown how vimentin
and PSF cooperatively contribute to IbeA-induced cellular
signaling and bacterial invasion.
Our recent studies have demonstrated that the IbeA/Vim-
mediated signaling is essential for NF-kB activation and PMN
transmigration across the BBB, two additional hallmark features of
bacterial meningitis [5,24–26]. There is a dual role for PMN
recruitment to the CNS. PMN transmigration across the BBB is not
only a key aspect of the protective response against invading
pathogens, but leukocytes also contribute importantly to the
deleterious effects of inflammation on the CNS tissues in bacterial
meningitis, which results in devastating neurologic sequelae [27].
Both in vitro and in vivo studies suggest that IbeA and vimentin are
essential for E. coli K1-induced PMN transmigration across the
BBB. Vimentin on both endothelial cells and PMN is able to form
an anchoring structure at the site of contact between these two cell
types. Vimentin contributes to PMN transmigration across the BBB
in response to meningitic infection in a manner substantially similar
to the traversal of lymphocytes across peripheral endothelial cells
[28]. E. coli-induced PMN transmigration could be markedly
inhibited by withaferin A, a dual inhibitor of vimentin and
proteasome. IbeA-induced PMN migration could be also blocked
by PS-341 (bortezomib), a proteasomal inhibitor, and correlated
with up-regulation of vimentin, ICAM-1, and CD44 expression
through proteasomal regulation of NF-kB activity [5]. Vimentin
could stabilize adhesion molecules and Scribble by protecting them
from proteasomal degradation [5]. These findings suggest that IbeA
is able to induce nuclear translocation of NF-kB and upregulate
vimentin that are correlated with E. coli K1-stimulated PMN
transendothelialmigrationandinflammatoryresponse.Currently,it
remains elusive how IbeA contributes to both bacterial invasion and
PMN transmigration through its interactions with vimentin/PSF
and upregulation of NF-kB activity.
The NF-kB signal transduction pathway, which is the master
regulator of the innate immunity, plays important roles in
maintaining cell homeostasis/differentiation, and regulating the
host response to microbial infections [29]. NF-kB proteins consist of
five different members, p65/RelA, c-Rel, RelB, NF-kB2/p52, and
NF-kB1/p50, sharing a Rel homology domain that mediates DNA
binding and dimerization [30]. In resting cells, NF-kB is trapped in
the cytoplasm by inhibitory IkB proteins. The NF-kB activation
process is induced by phosphorylation of serine residues on the IkB
proteins, which are then subjected to ubiquitination and proteaso-
mal degradation. Deregulated activity of this pathway has been
linked to the progression of a number of human diseases, including
cancers and microbial infections [29]. For example, NF-kB
activation has been shown to contribute to N. meningitidis invasion
of epithelial cells [31] and H. pylori-induced inflammation in gastric
epithelium [32]. NF-kB in the CNS is activated during bacterial
meningitis [24]. NF-kB inhibitors have been found to reduce the
CNS inflammation and to protect rat brains from inflammatory
injury following transient focal cerebral ischemia [33] and
pneumacoccal meningitis [25]. Our studies suggest that IbeA
induces all three of the hallmark features of bacterial meningitis:
NF-kB activation, pathogen invasion and PMN transmigration
across the BBB [4–6]. The underlying mechanisms for these
pathogenicities, however, require further investigation. Recently,
vimentin has emerged as a signaling platform of a number of critical
proteins at the cell surface, which contribute to the invasive
phenotypes of cancer, E. coli-induced pathogenicities, and cell
signaling [5–6,34]. PSF’s main function as a nuclear protein is to
contribute to the promotion of pre-mRNA splicing and transcrip-
tional regulation [3,35]. These findings suggest that vimentin and
PSF may cooperatively contribute to the early and late signaling
events induced by IbeA, allowing us to speculate that NF-kB
activation is mainly mediated by vimentin and that PSF plays a
major role in both cytoplasmic activation and nuclear translocation
of NF-kB. To clarify these issues, we investigated in this study the
role of vimentin and PSF in IbeA-induced NF-kB signaling.
Results
IbeA-induced E. coli K1 invasion, PMN transmigration and
IKK/NF-kB activation are blocked in vitro and in vivo by
Caffeic acid phenethyl ester (CAPE), an inhibitor of NF-kB
Our previous studies suggest that NF-kB activation may play a
key role in IbeA-induced bacterial invasion and PMN transmi-
gration [4–5]. However, the underlying mechanism is unclear. In
order to dissect this issue, CAPE, a specific inhibitor of NF-kB, was
used to determine the role of NF-kB signaling in both IbeA+ E. coli
K1 induced Invasion and PMN transmigration. As shown in
Fig. 1A, IbeA+ E. coli (E44) could significantly increase
phosphorylation of IKK a/b and NF-kB translocation to the
nucleus when compared to the IbeA deletion mutant ZD1 and the
control without treatment. These cellular effects were remarkably
reduced by inhibition of NF-kB signaling with CAPE. CAPE
could also significantly block IbeA+ E. coli K1 (E44)-induced
invasion of HBMECs and PMN transmigration in a dose-
dependent manner (Figure 1B and 1C). However, the dose-
dependent effects on PMN transmigration could not be observed
with the ibeA mutant ZD1 under the same experimental conditions
(Figure 1C). Residual effects of CAPE-mediated inhibition on ZD1
were also observed, indicating that other virulence factors might
be regulated by NF-kB. To further confirm these in vitro findings,
mice were pre-treated with CAPE for 3 days and then infected
with E44. As shown in Fig. 1D–F, CAPE was able to significantly
reduce the levels of PMN, albumin and NF-kB in CSF. Overall,
these findings suggest that the NF-kB signaling pathway plays an
important role in IbeA+ E. coli K1 induced Invasion and PMN
transmigration across HBMECs.
MEK/ERK signaling mediates IKK complex and NF-kB
activation in response to IbeA+ E. coli K1 infection of
HBMECs
The MAPK/ERK signaling pathway, a chain of proteins
communicating a signal from a receptor on the cell surface to the
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response to Ras activation [36] or anthracycline drug treatment
[37]. We have demonstrated that ERK phosphorylation is
required for IbeA-induced E. coli K1 invasion [4]. Binding of
vimentin to phospho-ERK can protect the activated kinase from
dephosphorylation [38]. PSF contributes to IGF-I-mediated
regulation of ERK through association and dissociation of p-
ERK [23]. Thus, we sought to determine whether IbeA-ERK
activation could also promote activation of NF-kB through the
MEK/ERK signaling pathway. PD098059, an ERK inhibitor,
was first used to examine the role of ERK phosphorylation in
IbeA+ E. coli-induced NF-kB activation. Figure 2A showed that
E44 could increase phosphorylation of Erk1/2 and IKK a/b,
degradation of IkBa after 30 min of incubation, and NF-kB
translocation to the nucleus after 2 h of infection when compared
to the IbeA deletion mutant ZD1 and the control without
treatment. We then used synthetic ERK peptides ERK89
(vimentin-binding domain) and ERK312 (non-binding peptide)
to examine whether the vimentin-binding domain of ERK was
essential for IbeA+ E. coli-induced NF-kB activation. As shown in
Figure 2B, ERK89 was able to block the Erk1/2 and IKK a/b
phosphorylation, IkBa degradation, and NF-kB translocation to
the nucleus when compared to the control peptide ERK312. It
suggests that the regulation of ERK by vimentin is important for
IbeA+ E. coli-induced NF-kB activation based on its protection
effect on ERK phosphorylation. Taken in consideration together,
these results demonstrated that the MEK/ERK signaling pathway
is critical for IbeA+ E. coli K1-induced cytoplasmic activation and
nuclear translocation of NF-kB.
IbeA+ E. coli K1 induced NF-kB activation is vimentin-
dependent
Since IbeA+ E. coli K1 was able to induce extensive vimentin
reorganization in HMBECs [4], we assumed that this change was
involved with IbeA+ E. coli K1-induced NF-kB activation. In order
to dissect this issue, immunofluorescence microscopy was used to
examine the colocalization of vimentin and NF-kB. Figure 3A
showed that there were very few changes in vimentin reorgani-
zation and NF-kB translocation occurring in the control without
any treatment or HBMECs treated with the IbeA deletion mutant
ZD1 after 2 hours of incubation, while E44 and IbeA could
strongly induce both vimentin rearrangements and NF-kB
translocation to the nucleus. The cytoplasmic NF-kB is clustered
and colocalized with vimentin rearrangements (indicated by
arrows). We used siRNA-mediated knockdown to further examine
the role of vimentin in IbeA+ E. coli K1-induced NF-kB activation.
Figure 1. Effects of CAPE on IbeA+ E. coli K1-induced NF-kB activation and pathogenicities in vitro and in vivo. (A) IbeA+ E. coli K1
induced NF-kB activation in HBMECs was suppressed by CAPE. HBMECs were incubated with or without the NF-kB inhibitor CAPE (25 mM) for 30 min
before stimulation with E44 or ZD1 (10
7/mL). IKK a/b phosphorylation (p-IKK a/b) in cytoplasmic fractions and NF-kB (p65) in nuclear fractions was
examined after 2 h of stimulation with E. coli strains. The b-actin in both fractions was detected as internal loading controls. CON, control without E.
coli stimulation. (B–C) Effects of CAPE (0–25 mM) on IbeA+ E. coli K1 penetration and PMN transmigration across HBMECs were examined. HBMECs
were incubated with various concentrations of CAPE for 1 h before the invasion and PMN transmigration assays. (B). E. coli (10
7 CFU) were added to
the HBMEC monolayers after CAPE treatment. Invasion assays were carried out as described in the Materials and Methods. (C) The CAPE-pretreated
HBMECs were stimulated with E. coli (10
6 CFU) in the lower chamber for 2 h and incubated with PMN (10
6) in the upper chamber at 37uC for another
4 h. All assays were performed in triplicates. Results for invasion are expressed as relative invasion compared to the positive control without drug
treatment (100%). Results for PMNT are expressed as the percentage of leukocyte transmigration of the total added. Both the invasion and PMNT
assays were done with E44 (black column) and ZD1 (white column). E. coli meningitis was induced in neonatal mice with or without CAPE treatment
(n=5) as described in Methods and Materials. (D) Recruitment of PMN into the CSF; (E) Flux of albumin into the CNS; and (F) Levels of soluble NF-kB
(p65) in CSF. The significant differences with regard to the controls without CAPE treatment were marked by asterisks (*P,0.05; **P,0.01).
doi:10.1371/journal.pone.0035862.g001
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and PSF were significantly reduced in vimentin siRNA-transfected
cells. Erk1/2 and IKK a/b phosphorylation, IkBa degradation,
and NF-kB translocation to the nucleus were significantly reduced
in all treatments of HBMECs transfected with vimentin siRNA.
These results suggest that vimentin is required for IbeA+ E. coli
K1-induced NF-kB activation.
Time course analysis of IbeA-induced cytoplasmic
activation and nuclear translocation of NF-kB
As shown in our previous studies [4–5], vimentin and PSF may
play sequential roles in the early and late signaling events induced
by IbeA. Because the mechanisms by which IbeA induces
signaling are still poorly understood and the molecular players
responsible for the initiation of NF-kB activation and subsequent
nuclear translocation are not clear, we performed time course
analysis of IbeA-induced NF-kB activation and translocation.
HBMECs were treated with IbeA at different time points (2–24 h).
Since vimentin is the primary receptor of IbeA, we first examined
its interactions with PSF, NF-kB and other signaling molecules by
co-immunoprecipitation (Co-IP) of vimentin and NF-kB (p65).
The protein lysates from cytoplasmic fractions were examined and
used as positive controls for Co-IP assays. As shown in Figure 4A,
IbeA could increase expression of vimentin, a7 nAChR, and PSF,
phosphorylation of IKK a/b, and degradation of IkBa in the
cytoplasm. Meanwhile, IbeA also significantly enhance the protein
content of p65 in nuclear fractions and PSF in both cytoplasmic
and nuclear fractions in a time-dependent manner. The Co-IP
assay with a mouse monoclonal antibody against vimentin showed
that proteins in the Co-IP complex including NF-kB (p65), IkB,
and b-tubulin decreased in a time-dependent manner (Figure 4B),
while IbeA could markedly enhance vimentin expression.
However, PSF was dramatically increased upon prolonged
stimulation with IbeA. These results suggested that there was an
increased dissociation of vimentin with IkBa, NF-kB and b-
tubulin, meanwhile an association of vimentin with PSF was
increased throughout the time course of stimulation with IbeA.
Similar patterns of changes in vimentin, IkBa, NF-kB, b-tubulin
and PSF were observed in the Co-IP assay with the rabbit anti-p65
antibody (Figure 4C). These findings suggest that vimentin and
PSF cooperatively contribute to the early (cytoplasmic activation)
and late (nuclear translocation) events of IbeA-induced NF-kB
signaling. It appears that vimentin forms a complex with IkB, NF-
kB and tubulins in the resting cells. A dissociation of this complex
and a simultaneous association of PSF with NF-kB could be
induced upon the prolonged stimulation with IbeA.
Vimentin head domain is required for IbeA-induced NF-
kB activation and interaction with b-tubulin
To dissect the interaction between vimentin and NF-kB (p65) or
b-tubulin, we generated two lentivirus constructs with GFP fusion,
which express the vimentin head domain (GFP-VH) in N-terminal
and the vimentin rod and tail domains with a VH deletion (GFP-
VRT) in C-terminal as described in Materials and Methods [4].
The lysates of the lentivirus transduced HBMECs were first
subjected to Western blot to examine expression of the vimentin
fragment constructs. As shown in Figure S1A, a 72-kDa protein
(band a) in the GFP–VRT transductant, a 37-kDa protein (band b)
in the GFP–VH transductant, and a 27-kDa protein (band c) in
the GFP transductant were detected by a rabbit antibody against
GFP. Because the two anti-vimentin antibodies recognize the C-
terminal region (V9) and the N-terminal region (H84) [39],
respectively, we used them to detect the endogenous expression of
vimentin fragments. The results showed a 72-kDa protein (band a)
in the GFP–VRT transductant besides the native vimentin of 55-
kDa (band d) in all transduced cells with the V9 antibody, and a
37-kDa protein (band b) in the GFP–VH transductant besides the
native vimentin of 55-kDa (band d) in all transduced cells with the
H84 antibody. Since the Co-IP assays indicated that vimentin
could form a complex with IkB, NF-kB (p65) and b-tubulin in the
resting cells, we then performed a Co-IP assay with a mouse
monoclonal antibody against GFP tag using all the transduced
HBMECs without any treatment. The GFP-IP complexes were
detected with a rabbit antibody against GFP, a rabbit antibody
against NF-kB (p65), and a rabbit antibody against b-tubulin
(Figure 5A). The results showed a similar pattern to those in Figure
S1A using the GFP antibody, except some cleavages of GFP-VRT
and GFP-VH, perhaps due to the instability of the GFP fusion
proteins. Interestingly, both NF-kB (p65) and b-tubulin bind to the
N-terminal region, suggesting that the vimentin head domain
Figure 2. Inhibition of IbeA+ E. coli-induced IKK phosphorylation and NF-kB activation by MEK/ERK inhibitors. (A) HBMECs were
incubated with or without PD098059 (50 mM) for 60 min before stimulation with E44 or ZD1 (10
7/ml). (B) HBMECs were incubated with or without
ERK89 (vimentin-binding domain, 25 mg/ml) and ERK312 (control peptide, 25 mg/ml) for 60 min before infection with E44 or ZD1 (10
7/ml). In both (A)
and (B), ERK1/2 phosphorylation (p-Erk1/2), IKK a/b phosphorylation (p-IKK a/b) and IkBa degradation were examined in cytoplasmic fractions after
30 min of stimulation with E. coli K1 strains. NF-kB (p65) translocation to the nucleus was examined in nuclear fractions after 2 h of infection with E.
coli K1 strains. b-actin in both fractions was detected as internal loading controls. CON, control without bacterial stimulation.
doi:10.1371/journal.pone.0035862.g002
Role of Vimentin and PSF in NF-kB Signaling
PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e35862contributes to IbeA-induced NF-kB signaling in a coordinated
manner with microtubules. In order to further examine the role of
the VH domain in IbeA-induced NF-kB activation, the immuno-
fluorescence microscopy was next used to examine the effects of
the VH deletion on NF-kB (p65) translocation to the nucleus. The
GFP transductant was taken as a positive control. As shown in
Figure 5B, IbeA-induced NF-kB (p65) translocation to the nucleus
occurred in both the non-transduced HBMECs and GFP-
transduced HBMECs (indicated by arrows), suggesting that the
GFP lentivirus transduction did not affect the NF-kB pathway.
However, the GFP-VRT transductant was deficient in NF-kB
(p65) translocation to the nucleus (indicated by arrows), indicating
that the vimentin head domain is essential for IbeA-induced NF-
kB activation. The same results were also obtained with these
transductants upon IbeA+ E. coli (E44) infection, but these events
could not occur in the untreated controls of the GFP-VRT and
GFP transductants or the cells treated with ZD1. This further
confirmed the key role of the VH domain in this process (Figure
S1C). Western blot showed that the VH domain deletion
significantly inhibited the NF-kB pathway, including Erk1/2 and
IKK a/b phosphorylation, IkBa degradation, and NF-kB
translocation to the nucleus upon stimulation with both the IbeA
protein (Figure 5C) and IbeA+ E. coli (E44), but it did not occur in
the cells treated with ZD1 (Figure S1B). To further investigate the
interaction between vimentin and NF-kB-IkB complex, a pull-
down assay was performed using purified His-vimentin and Ni-
NTA resin column after incubation with total cell lysates of
HBMEC. As Shown in Figure S2, IkBa (Figure S2D) could
directly bind to vimentin when compared to the control with the
Ni-NTA resin only. All these findings suggest the involvement of
vimentin in IkBa binding and the role of the vimentin head
domain in IbeA-induced NF-kB activation.
Microtubule network is required for IbeA+ E. coli K1-
induced NF-kB activation
The GFP-tag Co-IP assay demonstrated that b-tublulin could
bind to the vimentin head domain, suggesting that these two kinds
of cytoskeletal filaments may coordinately contribute to NF-kB
signaling. Microtubules have been implicated in NF-kB activation
and translocation [40–42]. Thus, we further examined the role of
the microtubule network in IbeA-induced NF-kB activation.
Immunofluorescence microscopy was used to examine colocaliza-
tion of vimentin and b-tubulin upon stimulation with E44, ZD1
and IbeA. As shown in Figure 6A, both E44 and IbeA could
strongly induced b-tubulin reorganization, which was partially
colocalized with vimentin clusters around the perinuclear region
(arrows indicated), while very few colocalization areas were
detected in unstimulated cells or cells treated with ZD1. To
confirm whether the microtubule network participates in IbeA-
induced NF-kB signaling, microtubule inhibitors, including
colchicine, vincristine, and nocodazole, were used to examine
their inhibitory effects on IbeA-induced NF-kB activation. As
shown in Figure 6B, all these microtubule inhibitors could block
Erk1/2 and IKK a/b phosphorylation, and NF-kB translocation
to the nucleus, indicating that the microtubule network plays an
important role IbeA+ E. coli-induced cytoplasmic activation and
nuclear translocation of NF-kB.
Figure 3. Role of vimentin in IbeA+ E. coli K1-induced NF-kB activation. (A) Immunofluorescence microscopy was used to examine the
correlation between vimentin reorganization and NF-kB translocation to the nucleus after 2 h of stimulation with IbeA protein (0.1 mg/ml), E44 or
ZD1 (25 MOI). HBMECs were triple-stained with the V9 antibody against vimentin conjugated to FITC (green), the rabbit antibody against NF-kB (p65)
conjugated to rhodamine (red), and DAPI (blue). The merged images are shown in the right-hand panels (Merge). Arrows indicated cells with
colocalization of vimentin and NF-kB (p65) Scale bar, 50 mm. (B) Blockage of IbeA+ E. coli K1-induced NF-kB activation in HBMECs by siRNA-mediated
knockdown of vimentin. HBMECs were transfected with vimentin or control siRNA as described in Materials and Methods. After 24 h incubation, the
cells were treated with E44 or ZD1 (10
7/ml) for 30 min or 2 h. Vimentin (VIM), a7 nAChR, ERK1/2 phosphorylation (p-Erk1/2), IKK a/b phosphorylation
(p-IKK a/b), IkBa degradation, and PSF re-localization were examined in cytoplasmic fractions after 30 min of stimulation with E. coli K1 strains. NF-kB
(p65) translocation to the nucleus was examined in nuclear fractions after 2 h of incubation with E. coli K1 strains. b-actin in both fractions was
detected as internal loading controls. Control: HBMECs transfected with control siRNA; VIM KD: HBMECs transfected with vimentin siRNA; UNT:
Untreated HBMECs.
doi:10.1371/journal.pone.0035862.g003
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phosphorylation of ERK/IKK and nuclear translocation of
NF-kB were significantly blocked by siRNA-mediated
knockdown of PSF
As shown in Figures 4 and 5, PSF might contribute to nuclear
translocation of NF-kB. Thus, it is interesting to examine whether
IbeA-induced pathogenicities, activation of the key signaling
molecules (e.g., ERK and IKK) and nuclear translocation of
NF-kB could be blocked by knockdown of PSF. IbeA+ E. coli K1
penetration (Figure 7A) and PMN transmigration across HBMECs
(Figure 7B) were significantly inhibited by suppression of PSF
expression when compared to that of the ibeA mutant ZD1. Since
PSF is mainly present in the nuclei of resting cells and recruited to
the cell surface or raft microdomains upon stimulation with IbeA+
E. coli K1, it is necessary to examine its distribution in both the
cytoplasmic and nuclear fractions. We performed siRNA-mediat-
ed knockdown of PSF in HBMECs to examine the role of this
protein in IbeA+ E. coli-induced NF-kB signaling. As shown in
Figure 7C, cytoplasm and nucleus were completely devoid of PSF
in siRNA-treated HBMECs. PSF siRNA was able to completely
inhibit Erk1/2 and IKK a/b phosphorylation, IkBa degradation,
and NF-kB translocation to the nucleus, suggesting that PSF plays
an essential role in the signals for NF-kB activation/translocation
that are conveyed between the cytoplasm and nucleus. It has been
suggested that the cytoplasmic relocalization of PSF is regulated by
tyrosine phosphorylation [43]. We, therefore, examined whether
IbeA was able to induce tyrosine phosphorylation of PSF using the
Co-IP assay with an anti-phosphotyrosine antibody. As shown in
Figure 7D, tyrosine phosphorylation of PSF was significantly
increased upon the prolonged IbeA stimulation, which was
correlated with the increased PSF relocalization or expression
shown in Figure 3B, 4A, 5C and S1B. E44-induced PSF
relocalization was significantly reduced in HBMECs transfected
with vimentin siRNA (Figure 3B). Recruitment of PSF was also
remarkably suppressed in HBMECs transduced with the vimentin
head domain deletion construct upon stimulation with IbeA
(Figure 5C) and E44 (Figure S1B). These results suggest that
regulation of PSF by tyrosine kinases and vimentin may play a role
in IbeA-induced NFkB activation and translocation.
IbeA+ E. coli induced proteasomal degradation is
inhibited by siRNA-mediated knockdown of vimentin
and VH domain deletion
Our previous study demonstrated that the proteasome-regulat-
ed NF-kB played an important role in IbeA/vimentin-induced
expression of adhesion molecules and transmigration of PMNs
across HBMECs. WFA (withafferin A), a dual inhibitor of
vimentin [4,44] and the ubiquitin proteasome pathway [45–46],
could block IbeA-induced upregulation of ICAM-1/CD44 and
activation/translocation of NF-kB through a vimentin-dependent
mechanism [5]. Vimentin has been implicated in the stabilization
of the Scribble polarity protein by protecting it from proteasomal
degradation [45]. In order to further examine the role of vimentin
in the IbeA-induced proteasomal degradation, we examined the
colocalization of vimentin and polyubiquitinylated proteins using
immunofluorescence microscopy. As shown in Figure S3, the
polyubiquitinylated proteins were clustered and colocalized with
vimentin around the perinuclear region upon stimulation with the
Figure 4. Time course analysis of IbeA-induced cytoplasmic activation and nuclear translocation of NF-kB. HBMECs ware incubated
with the IbeA protein (0.1 mg/ml) for 2, 6, and 24 h, respectively, and then the cytoplasmic and nuclear fractions were extracted. The cytoplasmic
fractions were immunoprecipitated (IP) with the V9 anti-vimentin antibody and the rabbit anti-NF-kB (P65) antibody as described in Materials and
Methods. The cytoplasmic and nuclear lysates (A), vimentin Co-IP complexes (B), and NF-kB (p65) Co-IP complexes (C) were subjected to western
blot using the antibodies as described in Materials and Methods. CON: the IP control without primary antibodies incubation; 0 h: the control HBMECs
without IbeA stimulation.
doi:10.1371/journal.pone.0035862.g004
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or the cells treated with ZD1. The polyubiquitinylated proteins
also aggregated to small particles to colocalize with vimentin on
the cell membranes (indicated by arrows), which were called
aggresomes and play an important role in the proteasomal
degradation [47]. These results suggest that vimentin might
directly bind to polyubiquitinylated proteins to exert its protection
and inhibit their degradation. The immunoblotting analysis of
polyubiquitinylated proteins in HBMECs was consistent with the
microscopy examination, which showed that more polyubiquiti-
nylated proteins in HBMECs treated with the control siRNA were
induced by IbeA+ E. coli K1 than ZD1 or the non-treated control
(left panel in Figure 8A). However, siRNA-mediated knockdown of
vimentin resulted in stronger polyubiquitinylation than the control
siRNA for each treatment, suggesting that vimentin could exert a
protective role in proteasomal degradation (Figure 8A). Since the
VH domain has been demonstrated as the scaffold region for
many signaling proteins, we therefore hypothesized that the VH
domain might be required for its protection role in proteasomal
degradation. To test this hypothesis, the GFP–VRT transductant
with the VH domain deletion was used to examine the
polyubiquitinylated proteins in HBMECs treated with E44 or
ZD1. As shown in Figure 8B, the GFP–VRT transductant
contained considerably more polyubiquitinylated proteins when
compared to the GFP transductant. These results indicated that
the vimentin head domain is essential for its protective role in
proteasomal degradation. PDZ-containing proteins have been
implicated in the regulation of NF-kB signaling [48]. Since
Scribble, a PDZ protein, has been shown to be stabilized by
vimentin, we examined whether Scribble contributed to IbeA+ E.
coli-induced invasion and PMNs transmigration across HBMECs.
Effects of siRNA-mediated knockdown of vimentin and Scribble
Figure 5. Effects of vimentin head domain deletion on IbeA-induced NF-kB activation and interaction with b-tubulin. (A) The
cytoplasmic fractions of the GFP–VRT, GFP-VH and GFP transductants were extracted and immunoprecipitated (IP) using the mouse anti-GFP
antibody as described in Materials and Methods. The GFP-IP complexes were subjected to Western blotting using the rabbit polyclonal antibodies
against GFP, NF-kB (P65), and b-tubulin. Band a, GFP–VRT (72 kDa); band b, GFP-VH (37 kDa); band c, GFP (27 kDa); band d, NF-kB (P65), (65 kDa); and
band e, b-tubulin, (50 kDa). (B) Immunofluorescence images of the GFP–VRT and GFP transductants incubated with or without the IbeA protein
(0.1 mg/ml) for 2 h. The cells were double-stained with the rabbit antibody against NF-kB (p65) conjugated to rhodamine (red), and DAPI (blue).
Arrows indicate cells with NF-kB (P65) translocation to the nucleus, which was increased in the GFP transductants and reduced in GFP-VRT-
transduced HBMECs upon stimulation with IbeA. Scale bar, 50 mm. (C) Western blot of the transduced HBMECs treated with the IbeA protein (0.1 mg/
ml). ERK1/2 phosphorylation (p-Erk1/2), IKK a/b phosphorylation (p-IKK a/b), IkBa degradation, vimentin (VIM), GFP and PSF re-localization were
examined in cytoplasmic fractions after 30 min of IbeA stimulation. NF-kB (p65) translocation to the nucleus was examined in nuclear fractions after
2 h of IbeA incubation. b-actin in both fractions was detected as internal loading controls.
doi:10.1371/journal.pone.0035862.g005
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Figure S4A and S4B, the knockdown of both proteins could
equally suppress IbeA-mediated bacterial invasion and PMNs
transmigration, but not in the cells treated with ZD1. These results
implied that Scribble may contribute to IbeA-induced NF-kB
signaling.
Discussion
In this report, we show that NF-kB signaling induced by
meningitic E. coli K1 requires two IbeA-binding proteins, the
primary receptor vimentin and the co-receptor PSF. Our previous
studies have demonstrated that the specific interaction between
IbeA and its primary receptor vimentin is the upstream signaling
event, which is required for the caveolae/lipid raft-dependent
entry of E. coli K1 into HBMECs [4]. Subsequently, the co-
receptor PSF and activated signaling molecules (e.g., ERK,
caveolin-1) are recruited to the lipid raft microdomains. Further-
more, ERK, which is able to communicate a signal from a
receptor on the cell surface to the DNA in the nucleus, was shown
to be important for NF-kB activation in response to Ras activation
[36] or anthracycline drug treatment [37]. The current report
shows that vimentin forms a complex with IkB, NF-kB and
tubulins in the resting cells. A dissociation of this complex and a
simultaneous association of PSF with NF-kB could be increased by
IbeA in a time-dependent manner. IKK a/b phosphorylation is
completely abolished in HBMECs lacking vimentin and PSF.
ERK activation is entirely dependent on PSF. These findings
suggest that vimentin and PSF cooperatively contribute to IbeA-
induced cytoplasmic activation and nuclear translocation of NF-
Figure 6. b-tublulin is required for IbeA+ E. coli K1-induced NF-kB activation. (A) IbeA2 and IbeA+ E. coli K1-induced b-tubulin/vimentin
clustering and colocalization. Immunofluorescence microscopy was used to examine the clustering and reorganization of vimentin and b-tubulin
after 2 h of incubation with the IbeA protein (0.1 mg/ml), E44 or ZD1 (25 MOI). HBMECs were triple-stained with the V9 antibody against vimentin
conjugated to FITC (green), the rabbit antibody against b-tubulin conjugated to rhodamine (red), and DAPI (blue). The merged images are shown in
the right-hand panels (Merge). Arrows indicated cells with colocalization between vimentin and b-tubulin around the perinuclear region. Scale bar,
50 mm. (B) Blockage of IbeA+ E. coli K1-induced cytoplasmic activation and nuclear translocation of NF-kB (p65) in HBMECs by the microtubule
inhibitors. HBMECs were incubated with or without colchicines (Col, 2 mM), vincristine (Vin, 1 mM), nocodazole (Noc, 25 mg/ml) for 60 min before
stimulation with E44 or ZD1 (10
7/ml). Phosphorylation of ERK1/2 (p-Erk1/2) and IKK a/b (p-IKK a/b) was examined in cytoplasmic fractions after
30 min of E. coli K1 treatment. NF-kB (p65) translocation to nucleus in nuclear fractions was examined after 2 h of E. coli K1 incubation. b-actin in both
fractions was detected as internal loading controls. CON, control without bacterial stimulation.
doi:10.1371/journal.pone.0035862.g006
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nucleus.
The major intermediate filament protein vimentin is an
important marker of EMT (epithelial–mesenchymal transition).
The EMT phenotypes are usually associated with embryonic
development and the malignant conversion of epithelial tumor
cells [21,49]. The EMT phenotype in Ras-transformed epithelial
cells is suppressed by inhibition of NF-kB signaling. Blockage of
NF-kB is positively correlated with the suppression of vimentin
expression and inhibition of the invasive phenotype of prostate
cancer cells, suggesting that EMT may be used as a predictor of
certain cancers [50]. In concurrence with these findings, IbeA-
mediated PMN transmigration can be enhanced by upregulation
of vimentin through NF-kB activation [5]. Vimentin expression
may be upregulated by activated NF-kB, which binds to a
regulatory element (enhancer) in the promoter of the human
vimentin-encoding gene [51]. Furthermore, the regulatory role of
vimentin in NF-kB activation has been implicated in our recent
studies on the effects of vimentin blockage on gene expression,
which shows significant inhibition of NF-kB in the nuclei of
HBMECs lacking vimentin [5]. Here, we have further demon-
strated that vimentin could contribute to regulation of NF-kBb y
forming a complex with IkB, NF-kB and tubulins in the resting
cells. This complex is dissociated upon the prolonged stimulation
with IbeA. As reported by Georgatos et al. in 1985 [52–53],
oligomeric species of vimentin bind to human erythrocyte
membranes through its head domain-mediated interactions with
ankyrin. Since IkB proteins contain multiple ankyrin repeats [54],
it is most likely that the head domain of vimentin binds to the
ankyrin domains of the IkB proteins. Our results have demon-
strated for the first time that the vimentin head domain is essential
for its interactions with IkB/NF-kB. It remains to be determined
whether this binding requires phosphorylation or other modifica-
tions of vimentin. There are two different types of vimentin
proteins, the insoluble (e.g., receptors) and the soluble (e.g.,
secreted), which contribute to bacterial pathogenesis. Vimentin on
Figure 7. Inhibition of IbeA+ E. coli K1-induced pathogenicities, phosphorylation of ERK/IKK and nuclear translocation of NF-kBb y
knockdown of PSF. HBMECs were transfected with PSF or control siRNA as described in Materials and Methods. IbeA+ E. coli K1 penetration (A) and
PMN transmigration (B) across siRNA-transfected HBMECs were performed as described in the Materials and Methods. Both invasion and PMN
transmigration assays were performed in triplicates. Results for invasion are expressed as a relative percentage compared to the penetration rate of
E44 in the siRNA control (CON) (100%). Results for PMN transmigration are expressed as the percentage of PMN transmigration of total PMNs. The
control siRNA-transfected HBMECs infected with E44 and ZD1 were used as the controls (panels A and B). The significant differences regarding to the
control were marked by asterisks (*P,0.05; **P,0.01). (C) After transfection, the cells were stimulated with E44 or ZD1 (10
7/ml) for 30 min or 2 h. PSF
re-localization, p-Erk1/2, p-IKK a/b and IkBa degradation were examined in cytoplasmic fractions after 30 min of stimulation with E. coli K1 strains. NF-
kB (p65) and PSF in nuclear fractions were examined after 2 h of incubation with E. coli K1 strains. b-actin in both fractions was detected as internal
loading controls. Control: HBMECs transfected with control siRNA; PSF KD, HBMECs transfected with PSF siRNA; UNT: Untreated HBMECs. (D) Time
course analysis of IbeA-induced tyrosine phosphorylation of PSF. HBMECs were incubated with the IbeA protein (0.1 mg/ml) for 2, 6, and 24 hrs,
respectively. The cytoplasmic fractions were extracted and immunoprecipitated (IP) using the anti-phosphotyrosine antibody as described in
Materials and Methods. The Tyr-IP complexes were subjected to Western blot using the mouse monoclonal antibody against PSF. Total mouse IgG
was detected as an internal loading control. CON: the IP control without primary antibody incubation; 0 h: the control HBMECs without IbeA
incubation.
doi:10.1371/journal.pone.0035862.g007
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and plays an essential role in IbeA+ E. coli K1-induced NF-kB
signaling, bacterial invasion and PMN migration across the BBB
[4–5]. However, the soluble vimentin, which can be modified and
secreted by macrophages [55] and EC [56], may be involved in
microbial infections in a manner similar to the soluble receptors.
Their exact relationship with pathogen-induced signaling may
warrant further studies. Microtubules may also interact with IkB
proteins in the same way as vimentin because they bind to ankyrin
domain-containing proteins [57–58]. As shown in our previous
studies, IbeA-induced NF-kB activation and translocation are
abolished by the blockage of vimentin (whithaferin A) and the
ubiquitin proteasome system (UPS) (PS-341) [5]. These blockages
resulted in accumulation of ubiquitinated proteins in the cytosol,
suggesting the involvement of vimentin and UPS. The current
studies show that IbeA-induced E. coli K1 invasion and PMN
transmigration across HBMECs are significantly blocked by
siRNA-mediated knockdown of Scribble, a PDZ domain-contain-
ing protein regulated by vimentin [45], suggesting that vimentin
contributes to IbeA-induced activation and nuclear translocation
of NF-kB in coordination with UPS and Scribble. The PDZ
protein, DLIM2, has been recently identified as a novel regulator
of NF-kB [48]. Defining the role of vimentin, UPS and Scribble in
IbeA-induced signaling may add a new layer to the mechanics of
NF-kB regulation.
PSF exhibits multiple functions, including the binding of nucleic
acids (DNA and RNA) and proteins, DNA pairing, promotion of
pre-mRNA splicing, and transcriptional regulation [35]. PSF has
been shown to be one of the key factors mediating the
posttranscriptional regulation of HIV-1 and causes a dose-
dependent inhibition of virus production in cell culture [59]. It
has been clearly established that PSF also contributes to the
regulation of gene expression mediated by several nuclear
hormones (e.g., thyroid hormone, progesterone, and androgens)
receptors via different mechanisms, including inhibition of DNA
binding, proteosomal receptor degradation, and/or recruitment of
coactivators such as the histone deacetylase (HDAC) complex
[23]. Transcriptional activity of several steroid receptors could be
blocked by overexpression of PSF through direct protein-protein
interactions with several transcriptional regulators [60]. Associa-
tion of PSF with pERK was recently found to be highly regulated
[23]. Insulin-like growth factor-I could dissociate the pERK-PSF
complexes, which would then result in integration of many
signaling events to allow dissociated pERK to access, phosphor-
ylate, and activate Sp1, thereby driving steroidogenesis [23]. We
have demonstrated that siRNA-mediated knockdown of PSF could
completely abolish phosphorylation of ERK and IKK, and
nuclear translocation of NF-kB, suggesting that PSF association
with pERK and pIKK may be one of the mechanisms
contributing to the regulation of IbeA-induced NF-kB signaling.
Recently, we demonstrated that p54nrb, a PSF protein partner,
could contribute to IbeA+ E. coli-induced pathogenicities [61].
Due to their dual RNA/DNA-binding properties and the ability to
interact with several protein counterparts, PSF and p54nrb might
contribute to multiple gene regulation processes, which may play a
crucial role in E. coli K1-induced activation and nuclear
translocation of NF-kB. Thus, it can be speculated that IbeA/
vimentin/PSF interactions may represent an important mecha-
nism responsible for a coordinated modulation of both bacterial
and host factors that contribute to bacterial invasion and PMN
transmigration. Further work is needed to examine how vimentin
and PSF cooperatively contribute to IbeA-induced NF-kB signal
transduction.
In this study we also show that functional microtubules are
required for the nuclear transport of transcription factor NF-kBi n
HBMECs upon stimulation with IbeA. Several microtubule
inhibitors (colchicine, vincristine, nocodazole) that can inhibit
tubulin polymerization decreased IbeA-induced nuclear translo-
Figure 8. Inhibition of IbeA+ E. coli K1-induced proteasomal degradation by knockdown of vimentin and VH domain deletion.
Immunoblotting analysis of polyubiquitinylated proteins (Ub-prs): (A) HBMECs with siRNA-mediated knockdown of vimentin; and (B) HBMECs
transduced with the lentivirus constructs expressing GFP–VRT and GFP. In both (A) and (B), all the cells were incubated with or without E. coli K1
strains (E44 and ZD1, 10
7/ml) for 2 h. The Ub-prs were detected in cytoplasmic fractions to determine the proteasomal degradation as described in
Materials and Methods. b-actin was used as an internal loading control. In all experiments, untreated HBMECs (UNT) were taken as controls.
doi:10.1371/journal.pone.0035862.g008
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colchicines and vincristine, could also block phosphorylation of
ERK and IKK. It has been shown that two major cytoskeletal
systems, actin filament and microtubule, are able to regulate the
NF-kB system [48,62–63]. It has been well established that there
are interactions or crosstalks between intermediate filaments and
microtubules [64]. Their close association in several cell types is
demonstrated by electron-microscopy studies. For example, these
two kinds of cytoskeletons form closely associated parallel arrays
throughout the cytoplasm of fibroblasts. A specific subset of stable,
detyrosinated microtubules (Glu-MTs) are shown to be involved in
these associations [64]. A crosstalk between intermediate filaments
and microtubules is suggested in the current studies as b-tubulin
binds to the head domain of vimentin. Understanding the
molecular basis of the crosstalk between vimentin intermediate
filaments and microtubules may be essential for determining the
mechanisms that underlie NF-kB activation.
In summary, the current studies with IbeA+ E. coli K1 infection
in HBMECs show that vimentin and PSF play an important role
in the pathogenesis of meningitic infection by contributing to
modulation of the early and late events of NF-kB signaling in a
coordinated manner. Cooperative contributions of vimentin and
PSF to IbeA-induced cytoplasmic activation and nuclear translo-
cation of NF-kB may represent a new paradigm in pathogen-
induced signal transduction and lead to the development of novel
strategies for prevention and treatment of bacterial meningitis.
Materials and Methods
Ethics statement
All research involving human participants has been approved
by the Institutional Review Board (IRB) of Children’s Hospital Los
Angeles (CHLA). Human polymorphonuclear leukocytes (PMNs)
were isolated from heparin anticoagulated, human peripheral
venous blood of healthy adult volunteers using the standard Ficoll-
Hypaque method in accordance with the protocol approved by the
CHLA Committee on Clinical Investigations (CCI), which is the
IRB for Human Subjects at Saban Research Institute of CHLA.
This protocol has been granted a waiver of informed or signed
consent per 45 CFR 46.116(d) and a waiver of HIPAA
authorization per the Privacy Rule (45 CFR Part 160 and
Subparts A and E of Part 164). No minors/children participants
were involved in our studies. The animal study was performed in
strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of
Health. Our protocols were approved by the Institutional Animal
Care and Use Committee (IACUC) of The Saban Research
Institute of CHLA (Permit number: A3276-01). All surgery was
performed under anesthesia with ketamine and lidocaine, and all
efforts were made to minimize suffering.
Chemicals and reagents
Dextran, polymyxin B resin, colchicine, vincristine, nocodazole
were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Restriction endonucleases and T4 DNA ligase were obtained from
New England Biolabs (Beverly, MA, USA). CAPE (caffeic acid
phenyl ester) and PD098059 were purchased from Calbiochem
(Darmstadt, Germany). Two peptides, ERK89 (vimentin binding
domain: RAPTIEQMKDVYIVQ) and ERK312 (control peptide:
EQYYDPSDEPIAEAP), were synthesized by GenScript (Piscat-
away, NJ, USA). Plasmid DNA was extracted by using the
MiniPrep kit (Qiagen Inc., Chatsworth, CA, USA). Mouse
monoclonal antibodies against GFP (T007) and His (T001) were
gifts from Epitope Biotech Inc. (Burnaby, Canada). All other
primary antibodies (Ab) and related reagents were purchased from
the following commercial sources: (A) rabbit polyclonal antibodies
against b-actin (sc-130657), vimentin (H84) (sc-5565), NF-kB (p65)
(sc-109), and GFP (sc-8334), and mouse monoclonal antibodies
against vimentin (V9) (sc-6260), and b-tubulin (sc-5274), and
Protein G and Protein A–agarose beads from Santa Cruz
Biotechnology (Santa Cruz, CA); (B) a mouse monoclonal
antibody against PSF (P2860) from Sigma-Aldrich(St. Louis,
MO, USA); (C) rabbit polyclonal antibodies against phospho-
ERK1/2 (Thr202/Tyr204) (#4370), phospho-IKK a/b (Ser176/
180) (#2697), b-tubulin (#2146), IKKb (#2678), and a mouse
monoclonal antibody against IkBa (#4814) from Cell Signaling
Technology (Danvers, MA); (D) a polyubiquitinylated proteins
mAb (FK1, BML-PW8805-0500) from Endo Life Sciences
(Farmingdale, NY); (E) a rat anti-mouse Ly-6G (Gr-1) Ab, from
eBiosciences (San Diego, CA); and (F) a rabbit polyclonal a7
nAChR Ab from Genescript (Piscataway, NJ). Transwell filters
(3 mm pore size, 6.5 mm diameter), blood plates and a mouse
monoclonal antibody against phosphotyrosine proteins were
purchased from BD Biosciences (San Jose, CA). Other chemicals
were purchased from Sigma-Aldrich unless otherwise noted.
Protein expression and purification
pET17A for expression of His6–IbeA was transformed into E.
coli BL21(DE3) cells. Expression and purification of recombinant
proteins in E. coli BL21 (DE3) cells were carried out according to
the manufacturer’s instructions (EMD Bioscience). Briefly, purifi-
cation of His6–IbeA was performed under the denaturing
condition (8 M urea) using Ni-NTA (Ni
2+- nitrilotriacetate)–
agarose columns. The eluted protein was dialyzed against
decreasing concentrations of urea in the same buffer as described
previously [19]. The purified IbeA protein was incubated with
polymyxin B resin to remove the potentially contaminated
lipopolysaccharide (LPS) [5]. The pull-down assay was carried
out as described previously [4]. Briefly, the Ni-NTA resin with or
without (control) purified native His–vimentin was incubated with
total cell lysates from HBMEC on a rocking platform overnight at
4uC, and then washed with wash buffer for five times. The pull-
down complex was released from Ni-NTA resin by boiling in
26SDS sample buffer, and then immunoblotted with mouse
antibodies against the His tag, vimentin (V9) and IkBa,
respectively.
Brain endothelial cells, E. coli strains and Invasion
HBMECs were kindly provided by Dr. Kwang S. Kim (John
Hopkins University) [65] and cultured as described previously [2–
8,66]. HBMECs were routinely cultured in RPMI 1640 medium
(Mediatech, Herndon, VA) containing 10% heat inactivated fetal
bovine serum, 10% Nu-serum, 2 mM glutamine, 1 mM sodium
pyruvate, essential amino acids, vitamins, penicillin G (50 mg/ml)
and streptomycin (100 mg/ml) at 37uC in 5% CO2. All the
phenotypes of HBMECs were described as previously [5]. E44 is a
rifampin-resistant derivative of E. coli K1 strain RS218 (serotype
018:K1: H7) [19,65]. ZD1 is an ibeA in-frame-deletion mutant of
E44 [19]. GFP (green fluorescent protein)-expressing E44 was
made by transformation with pHC60 encoding the gfp gene that is
constitutively expressed [67]. All strains were grown at 37uCi n
brain–heart infusion (BHI) media supplemented with rifampin
(100 mg/ml) and/or tetracycline (10 mg/ml) if required. E. coli
DH5a was used as the host strain for subcloning. E. coli invasion
was performed as described previously [19–20]. The inhibitor
CAPE was pre-incubated with the HBMEC monolayers for 1 h at
37uC before addition of bacteria and present throughout the
invasion experiment until the medium was replaced with
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of incubation. The released intracellular bacteria were enumerated
by plating on sheep blood agar plates. Cell viability was routinely
verified by the trypan blue staining assay. Results were expressed
as relative invasion percentage of invasion in comparison to that of
untreated HBMECs.
PMN isolation and transmigration assay
Neutrophils were isolated by dextran sedimentation of leuko-
cytes followed by Ficoll– Hypaque density gradient centrifugation
of PMN and hypotonic lysis of erythrocytes as previously described
[68–69]. PMN suspensions in experimental medium (EM;
containing 49% M199, 49% Ham’s F12, 1 mM sodium pyruvate
and 2 mM L-glutamine) were used for transmigration assays as
described previously [5,68–69]. Briefly, the confluence of the
HBMEC monolayers in transwell filters (3.0-mm pore size, 6.5-
mm diameter, BD Biosciences) was confirmed by light microscopy
before the start of the assay. The transwell filters were transferred
to clean 24-well plates, and washed twice with EM. The HBMEC
monolayers were pre-incubated with different doses of CAPE
(both in the upper and lower chambers) for 60 min, and stimulated
with E. coli K1 strains (10
6) in the lower chambers with 0.8 ml EM
for 2 h. Then, PMN (1610
6 cells in 0.2 ml of EM) were added to
the upper chamber and allowed to migrate over for 4 h. The
CAPE was present throughout the PMN transmigration experi-
ment until the end. At the end of the incubation, migrated PMN
cells were collected from the lower chamber and counted in a
blinded-fashion using a hemacytometer. Final results of PMN
transmigration were expressed as the percentage of PMN across
the HBMEC monolayers.
Mouse model of E. coli meningitis
The neonatal mice were randomly divided into two groups (5
mice each group). CAPE in 50% DMSO was administered for 3
days by intraperitoneal (i.p.) injection (10 mg/kg body weight
daily) [70]. The control group also received equal volume of 50%
DMSO at the same time. At 10 days of age, all pups received E.
coli K1 strain E44 (10
5 CFU) by i.p. injection. Eighteen hours after
E. coli inoculation, animals were anaesthetized with ketamine and
lidocaine. Sectioning of brain tissues and sampling of blood and
CSF were carried out as described previously [5]. To determine
PMN transmigration across the BBB, CSF samples were stained
with a FITC-conjugated rat anti-mouse Ly-6G (Gr-1) antibody
and counted under the fluorescence microscope. Albumin
concentrations in the CSF samples were determined using a
mouse Albumin ELISA kit from Bethyl laboratories (Montgomery,
TX) according to the manufacturer’s instructions. To measure
soluble NF-kB, five ml of the CSF samples were taken and
subjected to ELISA using rabbit polyclonal antibodies against NF-
kB (p65) from Santa Cruz Biotechnology according to the
manufacturer’s instructions.
Overexpression of vimentin head (VH) (RT deletion
mutant) and RT (VRT) (VH deletion mutant) domains in
HBMECs transduced with lentivirus constructs
The lentivirus constructs expressing GFP-VRT or GFP were
generated as described previously [4]. To make a lentivirus
construct expressing GFP-VH, VH cDNA was amplified with two
primer pairs: VH5 (5-TCCGGATCCATGTCCAC-
CAGGTCCGTG-3) and VH3 (5-ATGAATTCCTCGGTGTT-
GATGGCGTC-3) and then cloned into pEGFP-C1 (BD
Biosciences) at the BglII and EcoRI sites in the C-terminus of
GFP. The fragment GFP–VH was double-cut with the NheI/SalI
sites and cloned into pRRLsinhCMV (lentivirus vector) at the
XbaI/SalI sites. The lentivirus packaging, production and
transduction in HBMECs were described by Chen et al. [71].
After 48 h, conditioned medium was collected and filtered, and
the lentivirus stock was stored at270uC. The 60–80% confluent
HBMECs were infected with the lentivirus. The GFP expression
was examined under a fluorescence microscope at 48 h incubation
after lentivirus transduction. The transduced HBMECs with 70–
90% expression of GFP were subjected to western blotting,
fluorescence microscopy examination, and co-immunoprecipita-
tion as described below.
Vimentin, PSF and Scribble knockdown experiments
Knockdown experiments were performed using the human
vimentin, PSF and Scribble siRNA (small interfering RNA) kits
from Santa Cruz Biotechnology according to the manufacturer’s
instructions. siRNA duplex (60 pmol) was diluted with the
transfection medium and incubated with HBMECs. The cells
were incubated for 18–24 h. After replacing with fresh medium
and incubating for an additional 24 h, cells were used for invasion
assays, PMN transmigration assays, and western blotting analysis.
Immunoblotting analysis
To assess IbeA protein or IbeA+ E.coli K1 induced NF-kB
activation in HBMECs, endothelial cell monolayers were grown
on 60-mm plates. Confluent HBMEC monolayers were incubated
with E44, ZD1 (10
7/ml), or IbeA (0.1 mg/ml) for 30 min or
2 hours. For the blocking assays with inhibitors, HBMEC
monolayers were pre-incubated with or without CAPE,
PD098059, colchicine, vincristine, nocodazole and the ERK
peptides for 60 min, and then simulated with E44, ZD1 or IbeA as
described above. HBMECs with siRNA transfection or lentivirus
transduction were also stimulated with E44, ZD1 or IbeA as
described above. After the completion of incubation, cytoplasmic
and nuclear proteins of HBMECs were extracted with lysis buffer
supplied with 100 nM okadaic acid and 1 mM Na3VO4 as
described previously [46]. Both cytoplasmic and nuclear proteins
were mixed with SDS buffer, heated and subjected to sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS–PAGE).
Separated proteins were transferred to nitrocellulose membrane by
semi-dry blotting. After overnight blocking with 5% milk in PBS
with 0.1% Tween 20, membranes with cytoplasm proteins were
probed with antibodies against phospho-ERK1/2 (Thr202/
Tyr204) (0.2 mg/ml), phospho-IKK a/b (0.4 mg/ml), IkBa
(0.2 mg/ml, Cell Signaling Technology), vimentin (V9, 0.2 mg/
ml), a7 nAChR (0.1 mg/ml), PSF (0.2 mg/ml), b-actin (0.1 mg/ml)
for 2 hours, respectively. The membranes with nuclear proteins
were probed with antibodies against NF-kB (p65) (0.4 mg/ml), PSF
(0.2 mg/ml), and b-actin (0.1 mg/ml) for 2 h, respectively. For
proteasome activity examination, the membranes with cytoplasmic
proteins were incubated with a mAb against polyubiquitinylated
proteins (FK1, 0.2 mg/ml) for 2 h. The washed membranes were
incubated with a horseradish peroxidase (HRP)-conjugated
secondary antibody for 1 h and then visualized using an enhanced
chemiluminescence procedure (Roche Applied Science, Indianap-
olis, IN).
Co-immunoprecipitation
HBMECs grown in 100-mm-diameter dishes were washed with
cold PBS for 2 times after stimulated with IbeA (0.1 mg/ml) for
different times (2, 6, and 24 h). The cells were harvested, and the
cytoplasmic and nuclear proteins were extracted with 500 mlo f
lysis buffer as described above. One hundred ml of lysates were
taken from each fraction, and mixed with SDS sample buffer to
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cytoplasmic fractions (200 ml) were mixed with primary antibodies
against vimentin (V9) (4 mg/ml), NF-kB (p65) (4 mg/ml), and
phosphotyrosine proteins (4 mg/ml), respectively. For lentivirus
transduced HBMECs, the cytoplasmic proteins were also
extracted from untreated cells as described above, and mixed
with the mouse monoclonal antibody against GFP (4 mg/ml). All
the mixtures were incubated with gentle rocking overnight at 4uC,
and then added with Protein G–or Protein A–agarose beads for
additional gentle rocking for 1–3 h at 4uC. The lysates without
incubation with primary antibodies were also incubated with
Protein G–or Protein A–agarose beads to serve as negative
controls. After centrifugation five times at 8000 g for 30 s and
washing with lysis buffer, the pellet was resuspended with 30 mlo f
36SDS sample buffer. All the samples were analyzed by SDS/
PAGE (12.5%) and immunoblotted as described above with the
antibodies against IKKb (0.4 mg/ml), b-tubulin (0.4 mg/ml; the
rabbit Ab for the vimentin Co-IP complex and the mouse Ab for
the p65 Co-IP complex), IkBa (0.2 mg/ml), NF-kB (p65) (0.4 mg/
ml), a7 nAChR (0.1 mg/ml), vimentin (0.2 mg/ml; V9 for the p65
Co-IP complex and H84 for the vimentin Co-IP complex), PSF
(0.2 mg/ml), GFP (0.2 mg/ml; the rabbit Ab), and b-actin (0.1 mg/
ml), respectively.
Immunofluorescence microscopy
HBMECs transduced with or without lentivirus constructs were
grown in eight-well chamber slides coated with collagen and
incubated for 2 days, and stimulated with IbeA (0.1 mg/ml) or E.
coli K1 strains with or without GFP expression. The HBMEC
monolayers were then washed with PBS and fixed with 4% (w/v)
paraformaldehyde for 30 min at room temperature (25uC). After
blocking with 5% (w/v) BSA in PBS, the cells were stained with
the monoclonal antibody against vimentin (V9) (2 mg/ml)/FITC,
a polyclonal antibody against NF-kB (p65) (2 mg/ml,)/rhodamine,
a polyclonal antibody against b-tubulin (2 mg/ml)/rhodamine, or
a monoclonal antibody (IgM) against polyubiquitinylated proteins
(FK1, 2 mg/ml)/rhodamine. The cells were immersed with mount
medium containing 49-6-diamidino-2-phenylindole (DAPI) solu-
tion, and examined under a fluorescence microscope at the
Congressman Dixon Cellular Imaging Core Facility, Children’s
Hospital Los Angeles. To ensure the fluorescence strength of each
treatment in a comparable manner, all the images were acquired
with the same parameters.
Statistical analysis
All results given are means+2S.D. of triplicate determinations
in invasion and PMN transmigration assays. Raw data were
entered into MicrosoftH Excel files and were analyzed using the
statistical package. Software GraphPad Prsim 5.0 was used for
analysis of data from the animal experiments. P ANOVA and co-
variates were followed by a multiple comparison test. ,0.05 was
considered to be significant.
Database
The protein access codes in Swissprot database are listed as
follows: vimentin, Homo sapiens (Human), P08670; Transcription
factor p65 [NF-kB (p65)], Homo sapiens (Human), Q04206; NF-
kappa-B inhibitor alpha [IkBa], Homo sapiens (Human), P25963;
Extracellular signal-regulated kinase 1 [ERK1], Homo sapiens
(Human), P27361; Extracellular signal-regulated kinase 2 [ERK2],
Homo sapiens (Human), P28482; Tubulin beta chain [b-tubulin],
Homo sapiens (Human), P07437; Inhibitor of nuclear factor
kappa-B kinase subunit alpha [IKK a], Homo sapiens (Human),
O15111; Inhibitor of nuclear factor kappa-B kinase subunit beta
[IKK b], Homo sapiens (Human), O14920; PTB-associated-
splicing factor [PSF], Homo sapiens (Human), P23246 ; Neuronal
acetylcholine receptor subunit alpha-7 [a7 nAChR or CHRNA7],
Homo sapiens (Human), P36544; Protein scribble homolog
[Scribble], Homo sapiens (Human), Q14160; b-actin, Homo
sapiens (Human), P60709; Green fluorescent protein, [GFP],
Aequorea victoria (Jellyfish), P42212.
Supporting Information
Figure S1 Vimentin head domain is required for IbeA+
E. coli K1 induced NF-kB activation. (A) The cytoplasmic
proteins of GFP–VRT and GFP transductant were subjected to
Western blot using the rabbit anti-GFP antibody, the V9 antibody
against vimentin, and the H84 antibody against vimentin. Band a,
GFP–VRT (72 kDa); band b, GFP-VH (37 kDa); band c, GFP
(27 kDa); band d, vimentin (55 kDa). b-actin was used as the
internal loading control. (B) Western blot of GFP–VRT and GFP
transductant treated with E. coli K1 strains. p-Erk1/2, p-IKK a/b,
IkBa degradation and PSF re-localization were examined in
cytoplasmic fractions after 30 min of treated with E44 and ZD1.
NF-kB (p65) translocation to the nucleus was examined in nuclear
fractions after 2 h of incubation with E44 and ZD1. b-actin in
both fractions was detected as internal loading controls. CON:
control without bacterial stimulation. (C) Immunofluorescence
images of the GFP–VRT and GFP transductant stimulated GFP-
tagged E44 or ZD1 (25 MOI) for 2 h. The cells were double-
stained with the rabbit antibody against NF-kB (p65) conjugated
to rhodamine (red), and DAPI (blue). Scale bar, 25 mm. Arrows
indicated cells with NF-kB (P65) translocation to the nucleus,
which was increased in the GFP transductants and reduced in the
GFP-VRT-transduced HBMECs.
(TIF)
Figure S2 In vitro Pull-down assays to detect binding
between vimentin and IkBa. His–vimentin pull-down assays
were performed as described in Methods and Materials. The pull-
down complexes were detected by: Coomassie Brilliant Blue (CBB)
R-350 staining (A) and antibodies against the His6 tag (B),
vimentin (C) and IkBa (D).
(TIF)
Figure S3 Colocalization of IbeA2 or IbeA+ E. coli K1-
induced vimentin clusters with polyubiquitinylated
proteins. Immunofluorescence microscopy was used to examine
colocalization of vimentin clusters and polyubiquitinylated pro-
teins after 2 h of stimulation with IbeA (0.1 mg/ml), E44 or ZD1
(25MOI). HBMECs were triple-stained with the V9 antibody
against vimentin conjugated to FITC (green), the mouse antibody
(IgM) against polyubiquitinylated proteins conjugated to rhoda-
mine (red), and DAPI (blue). The merged images are shown in the
right-hand panels (Merge). Arrows indicated polyubiquitinylated
proteins in aggregates of small particles, which are colocalized with
vimentin on the cell membranes. Scale bar, 50 mm.
(TIF)
Figure S4 Inhibition of IbeA+ E. coli K1-induced
invasion and PMN transmigration across HBMECs by
knockdown of vimentin and Scribble. IbeA+ E. coli K1-
induced invasion (A) and PMN transmigration (B) were inhibited
by siRNA-mediated knockdown of vimentin (VIM) and Scribble
(Scrib). The siRNA-mediated knockdown of VIM and Scrib was
performed with HBMECs grown in 24-well plates or transwell
filters. After 24 h incubation, invasion and PMN transmigration
assays were carried out as described in the Materials and Methods.
The HBMECs in transwell filters were stimulated with E. coli K1
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6 CFU) in the lower chambers for 2 h before adding
PMN (10
6) in the upper chambers. Both invasion and PMN
transmigration assays were performed in triplicates. Results for
invasion are expressed as a relative percentage compared to the
penetration rate of E44 in the siRNA control (CON) (set as 100%).
Results for PMN transmigration are expressed as the percentage of
PMN transmigration of total added PMNs. The control siRNA-
transfected HBMECs infected with E44 and ZD1 were taken as
the controls (panels A and B). The significant differences regarding
to the control were marked by asterisks (*P,0.05; **P,0.01).
(TIF)
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